Cheung M C, Mendez A J, Wolf A C, Knopp R H
Department of Medicine, School of Medicine, University of Washington, Seattle.
J Clin Invest. 1993 Feb;91(2):522-9. doi: 10.1172/JCI116231.
A 48-yr-old Caucasian female of central European origin (subject IM) with low plasma cholesterol and normal plasma triglyceride (TG) had extremely low apo A-I (6 mg/dl), A-II (5 mg/dl), and HDL cholesterol (2 mg/dl) levels. She had most of the clinical symptoms typically associated with Tangier disease, including early corneal opacities, yellow-streaked tonsils, hepatomegaly, and variable degrees of peripheral neuropathy, but had no splenomegaly. She had a myocardial infarction at age 46. Since HDL are postulated to be involved in the transport of excess cholesterol from peripheral tissues to the liver for degradation, and the ability of an HDL particle to promote cellular cholesterol efflux appears to be related to its density, size, and apo A-I and A-II contents, we isolated and characterized the HDL particles of this patient and all her first degree relatives (mother, a brother, and two children). The plasma A-I, A-II, and HDL cholesterol levels of all five relatives were either normal or high. Using anti-A-I and anti-A-II immunosorbents, we found three populations of particles in IM: one contained both apo A-I and A-II, Lp(AI w AII); one contained apo A-I but no A-II, Lp(AI w/o AII); and the third (an unusual one) contained apo A-II but no A-I, Lp(AII). Two-thirds of her plasma A-I and A-II existed in separate HDL particles, i.e., in Lp(AI w/o AII) and Lp(AII), respectively. Only Lp(AI w AII) and Lp(AI w/o AII) were present in the plasma of the relatives. All three populations of the patient's HDL particles had a normal core/surface lipid ratio, but the cores were enriched with TG. The apo A-I-containing particles, however, were considerably smaller and contained much less lipid than Lp(AII). Despite these unusual physicochemical characteristics, the apo A-I-containing particles and Lp(AII) were effective suppressors of intracellular cholesterol esterification in cholesterol-loaded human skin fibroblast. The patient's plasma apo D and lecithin cholesterol acyltransferase levels were reduced, with an increased proportion located in non-HDL plasma fractions. These findings are discussed in light of Tangier disease and other known HDL-deficiency cases, and the role of HDL in the maintenance of cell cholesterol homeostasis.
一名48岁、祖籍中欧的白种女性(受试者IM),血浆胆固醇水平低,血浆甘油三酯(TG)正常,其载脂蛋白A-I(6毫克/分升)、A-II(5毫克/分升)和高密度脂蛋白胆固醇(2毫克/分升)水平极低。她具有大多数与丹吉尔病典型相关的临床症状,包括早期角膜混浊、扁桃体有黄色条纹、肝肿大以及不同程度的周围神经病变,但无脾肿大。她在46岁时发生过心肌梗死。由于推测高密度脂蛋白参与将外周组织中多余的胆固醇转运至肝脏进行降解,并且高密度脂蛋白颗粒促进细胞胆固醇流出的能力似乎与其密度、大小以及载脂蛋白A-I和A-II含量有关,我们分离并鉴定了该患者及其所有一级亲属(母亲、一个兄弟和两个孩子)的高密度脂蛋白颗粒。所有五位亲属的血浆A-I、A-II和高密度脂蛋白胆固醇水平均正常或偏高。使用抗A-I和抗A-II免疫吸附剂,我们在IM中发现了三类颗粒:一类同时含有载脂蛋白A-I和A-II,即Lp(AI w AII);一类含有载脂蛋白A-I但不含A-II,即Lp(AI w/o AII);第三类(一种不寻常的类型)含有载脂蛋白A-II但不含A-I,即Lp(AII)。她血浆中三分之二的A-I和A-II分别存在于单独的高密度脂蛋白颗粒中,即Lp(AI w/o AII)和Lp(AII)中。亲属血浆中仅存在Lp(AI w AII)和Lp(AI w/o AII)。患者的所有三类高密度脂蛋白颗粒的核心/表面脂质比率均正常,但核心富含TG。然而,含载脂蛋白A-I的颗粒比Lp(AII)小得多,脂质含量也少得多。尽管有这些不寻常的物理化学特征,但含载脂蛋白A-I的颗粒和Lp(AII)在胆固醇负荷的人皮肤成纤维细胞中是细胞内胆固醇酯化的有效抑制剂。患者的血浆载脂蛋白D和卵磷脂胆固醇酰基转移酶水平降低,且非高密度脂蛋白血浆部分中的比例增加。结合丹吉尔病和其他已知的高密度脂蛋白缺乏病例以及高密度脂蛋白在维持细胞胆固醇稳态中的作用对这些发现进行了讨论。